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Nontypeable Haemophilus influenzae (NTHi) is an im-
portant bacterial pathogen associated with lower respi-
ratory tract colonization and with acute exacerbations
and disease progression in chronic obstructive pulmo-
nary disease (COPD). Why the immune system fails to
eliminate NTHi and the exact contribution of the organ-
ism to COPD progression are not well understood, in
part because we lack an animal model that mimics all
aspects of COPD. For this study, we used an established
murine model that exhibits typical features of COPD.
Elastase/LPS-exposed mice infected with NTHi showed
persistence of bacteria up to 5 days after infection,
whereas mice exposed to elastase, LPS, or PBS cleared
all bacteria by 3 days. Elastase/LPS-exposed mice also
showed sustained lung neutrophilic inflammation, gob-
let cell metaplasia, airway hyperresponsiveness, and
progression of emphysema at 15 days after infection.
Alveolar macrophages isolated from elastase/LPS-ex-
posed mice showed impaired bacterial phagocytosis,
reduced expression of MARCO and of mannose recep-
tor, and absent expression of scavenger receptor-A (SR-
A). Neutralization of SR-A significantly decreased phago-
cytosis of NTHi by normal alveolar macrophages. Our
results suggest that elastase/LPS-exposed mice show im-
paired bacterial clearance and sustained lung inflamma-
tion. Lack of SR-A expressionmay, in part, be responsible
for impaired phagocytosis of bacteria by alveolar macro-
phages of elastase/LPS-exposed mice. These data validate
the suitability of elastase/LPSmodel for investigatingNTHi
pathogenesis and progression of disease in COPD. (Am J
Pathol 2012, 180:61–72; DOI: 10.1016/j.ajpath.2011.09.029)Chronic obstructive pulmonary disease (COPD) is a pro-
gressive disorder of the lung parenchyma and airways that
became the third-leading cause of death in the United
States in 2008.1,2 Acute exacerbations are associated with
disease progression and are also a major cause of morbid-
ity and mortality in COPD patients.3,4 Approximately two
thirds of all of the infectious exacerbations are associated
with bacterial infection, alone or in combination with respi-
ratory viruses.5,6 Acute exacerbations are associated with
the acquisition of new strains of nontypeable Haemophilus
influenzae (NTHi), Moraxella catarrhalis, and Streptococcus
pneumoniae and, in patients with severely reduced lung
function, Enterobacteriaceae and Pseudomonas species.7
The lower airways of some COPD patients are also chron-
ically colonized with bacteria readily detectable by conven-
tional culture-dependent methods; these patients show el-
evated markers of inflammation, compared with individuals
who do not show bacterial colonization by this methodol-
ogy.8,9 NTHi is the most frequently isolated bacterial patho-
gen from sputum of COPD patients under stable condi-
tions.10 Impaired innate immune defense mechanisms are
thought to contribute to the bacterial infection and persis-
tence of bacteria in these patients.
Alveolar macrophages are professional phagocytes that
play a critical role in the clearance of infecting bacteria while
preventing excessive pulmonary inflammation. Alveolar
macrophages express a variety of cell surface receptors
that are crucial for recognition and phagocytosis of patho-
gens and stimulating the appropriate immune response to
infection. Compared with alveolar macrophages from
healthy nonsmokers, alveolar and monocyte-derived mac-
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of common respiratory bacterial pathogens, including NTHi
and S. pneumoniae,11,12 and of apoptotic cells.13,14 Al-
though the importance of bacterial clearance seems evi-
dent, impaired efferocytosis (ie, clearance of apoptotic
cells) has also been linked to COPD progression.2,15 The
precise mechanisms for the observed defects in COPD are
unclear. Defining the molecular basis for defects in alveolar
macrophage phagocytic function could lead to novel ther-
apies to improve morbidity and mortality in COPD, which
typically progresses even after smoking cessation.
One family of receptors that plays a role in the host innate
defense against inhaled particles and pathogens is the
class A scavenger receptors, which include macrophage
receptor with collagenous structure (MARCO) and scaven-
ger receptor A (SR-A), which is expressed as SR-A I and
SR-A II in humans because of a splice variant and as a
single form (SR-A I/II) in mice.16–18 Both receptors were
shown to be required for efficient clearance of pneumo-
cocci from the lungs of infected mice16,17 and also for
protection against inhaled oxidants.18 Importantly, the risk
of developing COPD is increased in humans with mutations
in the macrophage scavenger receptor 1 gene, MSR1,
which encodes SR-A types I and II; thesemutations result in
expression of a receptor lacking the distal collagen-like
domain, which is essential in ligand recognition.19–21 Re-
duced efferocytosis by alveolar macrophages from COPD
patients was attributed in part to decreased expression of
surface receptors, including CD31, CD91 and CD44.14
However, these studies did not examine expression of SR-A,
which we previously showed is essential for optimal efferocy-
tosis bymurineperitonealmacrophages andmacrophagecell
lines.22 Collectively, these findings indicate the importance of
defining the possible role of alveolar macrophage scaven-
ger receptors in lung host defense and homeostasis.
To this end, we used an established experimental
model in which mice show structural and functional fea-
tures typical of human COPD, including pulmonary em-
physema, loss of lung elastic recoil, hyperinflation, goblet
cell metaplasia, markedly increased numbers of neutro-
phils, T and B lymphocytes, monocytes and macro-
phages in the airways and alveoli, and a deficiency in
clearing rhinovirus infection.23,24 Our results highlight the
importance of alveolar macrophage class A scavenger
receptors, especially SR-A, for clearance of NTHi.
Materials and Methods
Animals and Treatment
Normal 8- to 10-week-old C57BL/6mice (Charles River Lab-
oratories International, Wilmington, MA) maintained in a
specific pathogen-free environment were exposed to elas-
tase and LPS for four consecutive weeks, as described
previously.23,24 At 1 week after the last exposure to LPS,
mice were examined for susceptibility to bacterial infection.
Mice treated with PBS instead of elastase/LPS were used as
controls in all experiments. In selectedexperiments,micewere
exposed to elastase alone or LPS alone once a week for four
consecutive weeks. All experiments were approved by the
Animal Care andUseCommittee of theUniversity ofMichigan.Bacteria and Growth Conditions
NTHi (isolate 6P5H), isolated from a COPD patient at the
time of acute exacerbation, was kindly provided by T.F.
Murphy (University of Buffalo) and was maintained as
glycerol stock at 80°C. Bacteria were subcultured and
grown on chocolate agar, as described previously.25 In
some experiments, bacteria were labeled with either flu-
orescein isothiocyanate (FITC) (Pierce; Thermo Fisher
Scientific, Rockford, IL) or Alexa Fluor 555 (Invitrogen,
Carlsbad, CA), as described previously.26
Infection of Mice
After the 4 weeks of exposure to elastase/LPS, elastase,
LPS, or PBS, mice were anesthetized by intraperitoneal
injection of xylazine (1 mg/kg body weight) and ketamine
(50 mg/kg body weight) and infected with 50 L of NTHi
(5  107 CFU) or with the same volume of PBS (sham
infection) by the intratracheal route. Mice were euthanized
humanely at 1, 3, 5, or 15 days after infection for use in a
variety of assays; not all mice were used in each assay.
Lung Function Measurements
Mice were anesthetized and a steel cannula was inserted
into the trachea and connected to a miniature computer-
ized FlexiVent ventilator (Scireq, Montreal, QC, Canada).
To determine elastic recoil, lungs were gradually inflated
to 30 cm H2O; pressure and lung volume were then
measured continuously during inflation and deflation of
the lungs. Airway responsiveness to methacholine was
measured as described previously.23
Lung Histology
Lungs were inflation-fixed with 10% buffer formalin and
embedded in paraffin. Sagittal sections, 5 m thick, were
stained with H&E or PAS reagent.
Bacterial Persistence and Measurement of
Cytokines
Lungs were harvested from mice under aseptic condi-
tions and homogenized in 2 mL of PBS. Lung homoge-
nates were serially diluted and plated on chocolate agar
plates to determine the bacterial load. Homogenate su-
pernatants were used to determine protein levels of pro-
inflammatory cytokines by enzyme-linked immunosor-
bent assay (R&D Systems, Minneapolis, MN).
Measurement ofMuc5AC andMuc5B Expression
After RNA extraction, Muc5AC and Muc5B mRNA levels
were measured by quantitative real-time PCR using spe-
cific primers and probes.
Bronchoalveolar Lavage
Mice were euthanized and lungs were lavaged with PBS
containing 20 mmol/L EDTA; cells were collected by cen-
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veolar lavage fluid (BALF) were determined as described
previously.23 The cells were immunolabeled with antibod-
ies against CD45, CD11c, CD11b (eBiosciences, San
Diego, CA), SR-A, MARCO, mannose receptor, CD80,
and CD36 (AbD Serotec, Raleigh, NC) and analyzed on
an LSR II flow cytometer (BD Bioscience, San Jose, CA)
equipped with 488-nm blue, 405-nm violet, and 633-nm
red lasers, as described previously.23
Phagocytosis Assay
BALF cells from PBS or elastase/LPS-exposed mice were
centrifuged, suspended in RPMI 1640 medium containing
10% fetal bovine serum, seeded in two-chamber cover-
slipped glass slides (Invitrogen, Carlsbad, CA), and incu-
bated for 2 hours. The chamber slides were rinsed briefly
with medium to remove unattached cells and infected with
Alexa Fluor 555-labeled NTHi. Phagocytosis of bacteria in real
time was recorded for 30 minutes using a DeltaVision RT-live
cell imaging system (Applied Precision, Issaquah, WA).
In some experiments, resident alveolar macrophages
plated in chamber slides were infected with FITC-labeled
NTHi and extracellular fluorescence was quenched with
Trypan Blue, as described previously.26 The number of
cells positive for intracellular FITC-labeled bacteria was
counted under a fluorescence microscope equipped with
phase contrast to determine phagocytosis index.
The capacity of immortalized MH-S murine alveolar mac-
rophages (CRL-2019; ATCC, Manassas, VA) to phagocy-
tose NTHi was quantified by flow cytometry, as described
previously.26 Briefly, macrophages were seeded in six-well
plates and incubated with FITC-labeled NTHi at 10 MOI
(multiplicity of infection) for 1 hour. Cells were washed,extracellular fluorescence was quenched with Trypan Blue,
and then cells were analyzed by flow cytometry. In some
experiments, macrophages were pretreated with neutraliz-
ing antibody to SR-A (Cell Sciences, Canton, MA) or isotype
control for 1 hour at 37°C, infected with FITC-labeled NTHi,
and analyzed by flow cytometry as above.
Statistical Analysis
Results are presented as means  SEM. Data were an-
alyzed using SigmaStat statistical software (Systat Soft-
ware, San Jose, CA). One-way analysis of variance with
Tukey-Kramer post hoc analysis was performed to com-
pare more than two groups. To compare two groups, an
unpaired t-test with Welch’s correction was used. A
P value 0.05 was considered significant.
Results
Elastase/LPS-Exposed Mice Show Persistent
Pulmonary Bacterial Load and Lung Inflammation
Mice exposed to PBS or to elastase/LPS were infected
intratracheally with NTHi and euthanized at 1, 3, and 5
days after infection. Lung bacterial load was determined.
Although both PBS-exposed and elastase/LPS-exposed
mice showed bacteria in the lungs 24 hours after infec-
tion, only elastase/LPS-exposed mice showed persis-
tence of bacteria up to 5 days after infection (Figure 1A).
Bronchoalveolar lavage was performed to determine
the total and differential cell counts (Figure 1, B and C).
Both PBS-exposed and elastase/LPS-exposed mice
showed a 1-log increase in total cell counts 1 day after
NTHi infection, compared with their respective sham-
Figure 1. Persistence of NTHi and lung inflam-
mation. PBS-exposed or elastase/LPS-exposed
mice were either sham-infected with PBS and
euthanized 1 day after infection or infected with
NTHi and euthanized at 1, 3, or 5 days after
infection. A: Lung homogenates from NTHi-in-
fected mice were serially diluted and plated to
determine the bacterial load in the lungs. B and
C: Bronchoalveolar lavage was performed and
numbers of total cells and differential cell counts
were determined. D: Myeloperoxidase (MPO)
activity was assessed in total lung homogenates.
n  5 to 9 mice per group. *P  0.05 versus
PBS-treated mice, analysis of variance; †P  0.05
versus sham-infected mice, analysis of variance.
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87% of the cells in both groups. At 3 days after infection,
total cells decreased slightly in both groups of mice.
Neutrophilic inflammation persisted in both groups, but
was significantly higher in the elastase/LPS-exposed
group. By 5 days after infection, total and neutrophil cell
counts returned to baseline in the PBS group and were
similar to those of sham-infected controls. The elastase/
LPS-exposed mice, however, showed slightly increased to-
tal cell counts and sustained neutrophilic inflammation. To-
tal and differential cell counts in sham-infected animals on
days 3 and 5 were similar to those observed at 1 day after
infection (data not shown). Myeloperoxidase activity signif-
icantly increased in both groups at 1 day after infection,
compared with the respective sham-infected animals (Fig-
ure 1D). Although myeloperoxidase levels returned to nor-
mal levels in the PBS group, the elastase/LPS group
showed persistently increased myeloperoxidase levels,
consistent with the observed increase in BALF neutrophils.
H&E-stained lung sections from sham-infected animals
were histologically similar to those from the respective un-
infected mice. At 1 day after infection with NTHi, both PBS-
exposed and elastase/LPS-treated mice showed an inflam-
matory infiltrate, with neutrophils predominating (Figure 2,
A, B, and D–F). However, compared with the PBS group,
elastase/LPS-exposed mice showed more inflammation
(Figure 2, D–G). Whereas PBS-exposed mice showed lo-
calized accumulation of inflammatory cells in the peribron-
chiolar and perivascular areas, elastase/LPS-exposed mice
showed widespread neutrophilic inflammation, including in
the airway lumina and alveoli (Figure 2, E and F). At 5 days
after infection, the inflammation in PBS-exposed mice re-
solved completely (Figure 2C). In contrast, elastase/LPS-
exposed mice showed persistent inflammation up to 5 days
after infection (Figure 2G). Consistent with this observation,
we observed sustained increases in the proinflammatory
cytokines TNF-, IL-1, IL-6, KC, MIP-2, and CCL2 up to 5
days after NTHi challenge in elastase/LPS-exposed but not
PBS-exposed mice (see Supplemental Figure S1 at http://
ajp.amjpathol.org).
Elastase/LPS-exposed mice with sham infection
showed more PAS-positive material than the PBS-ex-
posed mice in both large and small airways, as observed
previously (Figure 3, A and B).23,24 PAS-positive cells
further increased after bacterial infection in elastase/LPS-
exposed mice (Figure 3, C and D), but not in similarly
infected PBS-exposed mice (Figure 3, E and F). RT-PCR
analysis indicated a significant increase in Muc5AC ex-
pression at 1, 3, and 5 days after infection in elastase/
LPS-exposed mice, but only 1 day after infection in PBS-
exposed mice (Figure 3G). There were no changes in
Muc5B expression in either group of mice.
NTHi Infection Affects Lung Function in
Elastase/LPS-Exposed Mice
To examine whether overt inflammation caused by bac-
terial infection was associated with altered lung function,
we examined pressure-volume relationships and airway
cholinergic responsiveness in mice 1 and 5 days afterinfection. Pressure-volume loops did not change signifi-
cantly in infected animals and were similar to those of un-
infected mice (data not shown). We also measured airway
responsiveness to increasing doses of nebulized metha-
choline. NTHi-infected, PBS-exposed mice showed no sig-
nificant increase in airway responsiveness, compared with
sham-infected mice at either 1 or 5 days after infection. In
contrast, elastase/LPS-exposedmice showed significant in-
Figure 2. Histology of mice infected with NTHi. Paraffin-embedded lung sections
from PBS-or elastase/LPS-exposedmice infectedwith NTHi were stainedwith H&E.
A: PBS-exposed mouse, 1 day after infection. B: Inflammatory cells seen at higher
magnification; the image corresponds to the area outlined in panelA.C: PBS-treated
mouse, 5 days after infection. D–F: Elastase/LPS-exposed mice at 1 day after infec-
tion. E: Neutrophils in the airway lumen seen at higher magnification; the image
corresponds to the area outlined in panelD. F:Neutrophils in the alveolar space.G:
Elastase/LPS-exposed mice exhibit moderate lung inflammation, 5 days after infec-
tion. Arrows indicate neutrophils; arrowheads indicate macrophages. Images are
representative of 3 mice from each group. Scale bars: 50 m (B, E, and F); 200 m
(A, C, D, and G).creases in airway responsiveness at both 1 and 5 days after
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tive to similarly treated PBS-exposedmice (see Supplemen-
tal Figure S2 http://ajp.amjpathol.org).
Elastase/LPS-Exposed Mice Infected with NTHi
Show Progression of Emphysema
To examine the long-term effects of NTHi infection on pro-
gression of lung disease, elastase/LPS-exposed mice were
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Figure 3. Mucin expression in NTHi-infected mice. Paraffin-embedded lung
sections from PBS-exposed or elastase/LPS-exposed mice infected with NTHi
were stained with PAS. A and B: Lung sections from sham-infected elastase/
LPS-exposed mice show PAS-positive cells in large (A) and small (B) airways.
C and D: Lung sections from elastase/LPS-exposed mice at 5 days after
infection show increased PAS-positive cells and PAS-positive material in large
(C) and small (D) airways. E and F: Lung sections from PBS-exposed mice at
5 days after infection show few PAS-positive cells in the large airway (E), but
not in the small airway (F). Arrows indicate PAS-positive cells and arrow-
heads indicate PAS-positive material in airway lumen. Images are represen-
tative of three animals per group. G: Total RNA was extracted from sham-
infected or NTHi-infected mice at 1, 3, or 5 days after infection. Muc5AC and
Muc5B gene expression determined by real-time PCR was normalized to
expression of -actin and expressed as fold increase relative to sham-infected
PBS-exposed mice. Data are presented as means  SEM (n  5 mice/per
group). *P  0.05 versus PBS-treated mice, analysis of variance; †P  0.05
versus sham-infected mice, analysis of variance. Scale bars: 50 m.infected with NTHi and sacrificed at 15 days after infection.Selected parameters were measured, including bacterial
load. None of the groups showed bacteria in their lungs
(data not shown). However, compared with sham-infected
mice, elastase/LPS-exposed mice infected with NTHi
showed small but significantly increased levels of CXCL-
1/KC protein (Figure 4A) and Muc5AC mRNA (Figure 4B),
but no difference in the expression of Muc5B mRNA (data
not shown). In contrast, PBS-exposed mice infected with
NTHi showed increases in neither CXCL-1/KC norMuc5AC
levels. Histological evaluation revealed persistence of mild
inflammation in both sham-infected and NTHi-infected elas-
tase/LPS-exposed mice, but not in similarly infected PBS-
exposed mice (Figure 4, C–E). We also observed sustained
goblet cell metaplasia in the small airways of elastase/LPS-
exposed mice, which appears to be slightly increased in
NTHi-infected mice (Figure 4, F–H). In contrast, mice ex-
posed to PBS did not show PAS-positive cells in the small
airways. Notably, NTHi-infected mice in both elastase/LPS
and PBS-exposed mice showed slightly leftward and up-
ward shift in pressure-volume curves compared with the
respective sham-infected control group (Figure 5A). This
shift was more pronounced in NTHi-infected elastase/LPS-
exposed mice, suggesting further loss of lung elastic recoil
in these mice. Consistent with this observation, NTHi-in-
fected elastase/LPS-exposed mice showed decreased
elastance and increased compliance, compared with sim-
ilarly exposed sham-infected mice. (Figure 5, B and C).
Taken together, these results indicate that changes caused
by acute NTHi infection may lead to progression of lung
disease in elastase/LPS-exposed mice in the absence of
detectable bacteria at late phase of infection.
Elastase/LPS-Exposed Mice Are Deficient in
Phagocytosis
To examine whether the persistence of bacteria in elastase/
LPS-exposed mice is caused by a deficiency in phagocy-
tosis of bacteria by alveolar macrophages, we performed ex
vivo phagocytosis assays. BALF resident alveolar macro-
phages obtained from PBS-exposed or elastase/LPS-ex-
posed mice were infected with Alexa Fluor 594-labeled
NTHi, and real-time phagocytosis was recorded under time-
lapse fluorescence microscopy. Macrophages from elas-
tase/LPS-exposed mice showed decreased capacity to
phagocytose bacteria, compared with macrophages from
PBS-exposedmice (see Supplemental Movies S1 and S2 at
http://ajp.amjpathol.org). Quantification of phagocytosis un-
der microscopy revealed that 78% of macrophages from
PBS-exposed mice were positive for intracellular bacteria,
whereas only 42% of macrophages from elastase/LPS-ex-
posed mice were positive (Figure 6A). It should be noted
that, although elastase/LPS-exposed mice have more mac-
rophages and monocytes put together, the number of res-
ident alveolar macrophages is significantly lower than in the
PBS-exposed mice (see below), and therefore it is possible
that fewer macrophages will be positive for bacteria in elas-
tase/LPS-exposed mice. Moreover, confocal imaging of
macrophages from PBS-treated mice 2 hours after infection
revealed degraded bacterial particles (Figure 6B), indica-
tive of efficient killing of phagocytosed bacteria. In contrast,
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tact bacteria on the cell surface and occasionally inside the
cells. These data indicate that macrophages from elastase/
LPS-exposed mice are not only deficient in bacterial phago-
cytosis but also appear to be deficient in killing of ingested
bacteria.
Elastase/LPS-Exposed Mice Have Decreased
Levels of Class A Scavenger Receptors
Class A scavenger receptors play a role in optimal
phagocytosis of bacteria by macrophages. We therefore
assessed the expression of SR-A and MARCO in macro-
phages from PBS and elastase/LPS-exposed mice. We
also examined expression of the class B scavenger re-
ceptor CD36, mannose receptor, and the costimulatory
receptor CD80. As observed previously, elastase/LPS-
exposed mice showed three times more total cells, com-
pared with PBS-exposed mice.23 In PBS-exposed mice,
the majority of CD45 BALF cells were also positive for
CD11c (Figure 7, A and B). In contrast, only 10% of
CD45 BALF cells from elastase/LPS-exposed mice
were CD11c single-positive and the rest were either
CD11b single-positive (recently recruited monocytes) or
double positive for both CD11c and CD11b (a population
termed exudate macrophages, which would also include
any dendritic cells). Because CD45 and CD11c single-
positive cells represent resident alveolar macrophages,we compared the expression of scavenger receptors in
this cell population. Compared with macrophages from
PBS-exposed mice, macrophages from elastase/LPS-ex-
posed mice showed decreased expression of MARCO
and of mannose receptor, increased expression of CD36,
and absent expression of SR-A (Figure 7C). There was no
difference in the expression of CD80 between PBS and
elastase/LPS-exposed mice. These results suggest that
SR-A may be at least in part responsible for the observed
defect in bacterial phagocytosis in these mice.
Mice Exposed to Elastase or LPS Alone Show
Normal Clearance of Bacteria
Previously, we have shown that exposure to both elastase
and LPS is required for inducing COPD phenotype includ-
ing susceptibility to rhinovirus infection in mice,23 but the
contribution of elastase or LPS alone to defective bacterial
clearance is not known. We therefore exposed mice to
elastase or LPS alone and determined their capacity to
clear bacteria from their lungs after NTHi challenge.We also
determined phagocytosis of bacteria by resident alveolar
macrophages ex vivo and expression of MARCO and SR-A
on CD45 and CD11c BALF cells. Unlike elastase/LPS-
exposed mice, mice exposed to elastase or to LPS cleared
all bacteria from their lungs by 3 days, similar to mice
exposed to PBS (data not shown). In addition, resident
Figure 4. Lung inflammation and mucus cell
metaplasia at 15 days after NTHi infection in
elastase/LPS-exposed mice. PBS-exposed or
elastase/LPS-exposed mice were sham-infected
or NTHi-infected and euthanized 15 days later.
A: Lung homogenate supernatant was analyzed
by enzyme-linked immunosorbent assay to de-
termine the CXCL-1/KC protein levels. B: mRNA
levels of Muc5AC was determined by quantita-
tive PCR using total RNA isolated from lungs.
Data are presented as means  SEM, calculated
from triplicate experiments (n  5 to 8 mice
total). *P  0.05 versus PBS-treated mice, anal-
ysis of variance; †P  0.05 versus sham-infected
mice, analysis of variance. C: H&E-stained lung
sections from PBS-exposed NTHi-infected mice
show no lung inflammation. D and E: H&E-
stained lung section from sham-infected (D) or
NTHi-infected elastase/LPS-exposed mice (E)
show peribronchiolar inflammation and emphy-
sema. F: PAS-stained lung sections from NTHi-
infected PBS-exposed mice show no PAS-posi-
tive cells. G and H: PAS-stained lung sections
from sham-infected (G) or NTHi-infected elas-
tase/LPS-exposed mice (H) show PAS-positive
cells in the airway. Arrows indicate PAS-posi-
tive cells. Images are representative of three an-
imals per group. Scale bars: 50 m (F–H); 200
m (C–E).macrophages isolated from mice exposed to elastase or
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sis (Figure 8A). Analysis of BALF cells revealed the pres-
ence of 1 log more total cells in both elastase and LPS-
exposed mice, compared with mice exposed to PBS, and
0.6 to 0.7 log fewer cells than in mice exposed to elastase/
LPS, as observed previously23 (Figure 8B). Mice exposed
to LPS alone or elastase alone showed a decrease in num-
Figure 5. Lung function in elastase/LPS-exposed mice at 15 days after NTHi
infection. PBS-exposed or elastase/LPS-exposed mice were sham-infected or
NTHi-infected; mice were anesthetized 15 days later, and pressure-volume rela-
tionships (A), compliance (B), and elastance (C) were measured with a FlexiVent
system. A: Each curve is representative of pressure-volume curves of three
mice/group. B and C: Data are presented as means  SEM, calculated from
triplicate experiments (n  3). *P  0.05 versus PBS-treated mice, analysis of
variance; †P  0.05 versus sham-infected mice, analysis of variance.ber of CD11c single-positive cells, compared with miceexposed to PBS, but the number of CD11c single-positive
cells was still higher than in mice exposed to the elastase/
LPS combination. Similar to mice exposed to elastase/LPS,
mice exposed to LPS alone or elastase alone also showed
increase in number of CD11b single-positive cells and cells
positive for both CD11b and CD11c, compared with PBS-
exposed mice. However, unlike mice exposed to elastase/
LPS, mice exposed to elastase alone or LPS alone did not
show significant reduction in the expression of either
MARCO or SR-A on CD45 and CD11c cells, compared
with mice exposed to PBS (Figure 8C). Taken together,
these results suggest that exposure to elastase alone or
LPS alone does not affect expression of MARCO or SR-A,
nor does it affect the capacity of mice to clear bacteria. In
addition, these results further support the notion that absent
expression of SR-A in elastase/LPS-exposed mice may
contribute to defective bacterial phagocytosis.
Neutralization Antibody to SR-A Decreases
Phagocytosis of NTHi by MH-S Alveolar
Macrophages
To determine the requirement of SR-A in NTHi phagocy-
tosis by alveolar macrophages, we used the MH-S mouse
Figure 6. Phagocytosis of bacteria by alveolar macrophages. Resident alve-
olar macrophages were isolated from mice exposed to PBS or elastase/LPS
for 4 weeks, seeded in coverslipped chamber slides, and infected with
FITC-labeled NTHi bacteria. A: After 30 minutes, extracellular fluorescence
was quenched with Trypan Blue and numbers of intracellular bacteria were
quantified under fluorescence microscopy (n  3). Data are presented as
means  SEM. *P  0.05 versus PBS-treated mice, unpaired t-test with
Welch’s correction. B: In some experiments, alveolar macrophages were
infected with Alexa Fluor 555-labeled NTHi, incubated for 2 hours, fixed,
counterstained with DAPI, and visualized under a confocal microscope.
Images are representative of three independent experiments. Original mag-
nification, 1000.
68 Ganesan et al
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previously to be efficient in bacterial phagocytosis.26 Ini-
tially, we examined the expression of SR-A in MH-S cells
Figure 7. Analysis of macrophages and expression of scavenger receptors.
BALF cells from PBS-exposed or elastase/LPS-exposed mice were immuno-
stained with a combination of labeled antibodies to CD45, CD11b, CD11c,
SR-A, MARCO, CD36, mannose receptor, and CD80 and were analyzed by
flow cytometry. A and B: CD45 cells were analyzed for the expression of
CD11b and CD11c. Flow scatter images (A) are representative of three
independent experiments. C: CD45 and CD11c cells were analyzed for
expression of SR-A, MARCO, CD36, mannose receptor, and CD80. Data in B
and C are presented as means  SEM, calculated from two independent
experiments (n  5 mice per experiment). *P  0.05 versus PBS-treated
mice, unpaired t-test with Welch’s correction.by flow cytometry and found that these cells expressedSR-A on the cell surface (Figure 9, A and B). To deter-
mine the contribution of SR-A in phagocytosis of NTHi,
MH-S cells were preincubated with neutralizing antibody
to SR-A or nonspecific IgG isotype control and then in-
fected with FITC-labeled NTHi. Cells were analyzed by
flow cytometry, after quenching of extracellular fluores-
cence. MH-S cells phagocytosed bacteria efficiently, and
this was not affected by preincubation with normal IgG
(the isotype control for SR-A antibody). In contrast, MH-S
cells preincubated with neutralizing antibody to SR-A
showed significantly fewer intracellular bacteria than the
cells incubated with isotype IgG control or NTHi alone
Figure 8. Bacterial phagocytosis and expression of MARCO and SR-A in mice
exposed to elastase or LPS alone. BALF cells were isolated from mice exposed
to elastase or LPS alone for four consecutive weeks. A: Resident alveolar mac-
rophages were seeded in coverslipped chamber slides and incubated with
FITC-labeled NTHi for 30 minutes; numbers of intracellular bacteria were quan-
tified under fluorescence microscopy. B and C: BALF cells were immunostained
with a combination of labeled antibodies to CD45, CD11b, CD11c, SR-A, and
MARCO and were analyzed by flow cytometry. Data are presented as means 
SEM, calculated from two independent experiments (n  3 to 6). *P  0.05
versus PBS-treated mice, unpaired t-test with Welch’s correction.
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crucially involved in phagocytosis of NTHi by murine al-
veolar macrophages. Taken together, these results sug-
gest that absent expression of SR-A in macrophages
from elastase/LPS-exposed mice may be in part respon-
sible for deficient bacterial phagocytosis, leading to the
persistence of bacteria in these mice.
Discussion
The principal findings of the present study demonstrate
exaggerated inflammation and impaired pulmonary
clearance of NTHi, a bacterial pathogen centrally impli-
cated in COPD pathogenesis, in a murine model that
exhibits typical histological and functional features of
COPD, including emphysema, chronic bronchitis, airway
remodeling, goblet cell metaplasia, and reduced elastic
recoil.23,24 After NTHi infection, elastase/LPS-exposed
mice (but not mice exposed to elastase alone or LPS
alone) show delayed bacterial clearance, defective
phagocytosis, decreased expression of mannose recep-
tor and MARCO, and absent expression of SR-A on res-
ident alveolar macrophages. Elastase/LPS-exposed mice
also showed increased levels of chemokines and proin-
flammatory cytokines, and neutrophilic lung inflammation
up to 5 days after infection. Further, we found that inhi-
bition of SR-A by neutralizing antibody decreases phago-
cytosis of bacteria in MH-S mouse alveolar macro-
phages. Thus, these data indicate the importance of
alveolar macrophage scavenger receptors, especially
SR-A, in defense against NTHi. Finally, elastase/LPS-ex-
posed mice infected with NTHi also showed progressionof emphysema at 15 days after infection. Together with
our previous demonstration that this model shows de-
layed viral clearance and increased inflammation during
rhinovirus infection,23 and can be ameliorated by the
antioxidant quercitin,24 these observations demonstrate
important advantages of elastase/LPS-exposed mice as
a practical in vivo model of established COPD.
COPD is a heterogeneous syndrome resulting from an
abnormal reaction to inhaled oxidant stress. The over-
whelming majority of cases in the developed world result
from tobacco smoking, but only a minority of smokers
develop COPD. Furthermore, fixed airflow obstruction
and a phenotype indistinguishable from COPD can also
develop in individuals with longstanding asthma who
have never smoked,27 and population-based surveys
have shown that chronic airflow limitation occurs in10%
of never-smokers 40 years old.28,29 Moreover, in the
developing world, where COPD incidence is increasing
even most rapidly, indoor air pollution from biomass fuels
may be a more common cause than smoking. These
epidemiological considerations point to the need for a
variety of experimental approaches to define mecha-
nisms relevant to COPD pathogenesis.
In this regard, we believe that our present murine
model importantly complements experimental models
that use cigarette smoke exposure, models that have
significant limitations. Short-term exposure models (3
weeks) predominately reveal acute and even toxic ef-
fects. Chronic models have been successful in modeling
emphysema development, but even after prolonged ex-
posures these models show minimal peribronchial inflam-
Figure 9. Role of SR-A in phagocytosis of bac-
teria by alveolar macrophages. A and B: Immor-
talized murine alveolar macrophage cells of the
MH-S cell line were incubated with antibody to
SR-A or isotype control and were analyzed by
flow cytometry to determine the expression of
SR-A. A: Representative histograms show ex-
pression of SR-A. B: Quantification of SR-A. C
and D: MH-S cells were preincubated with neu-
tralizing antibody to SR-A or isotype control or
medium and then were incubated with FITC-
labeled NTHi for 1 hour. Extracellular fluores-
cence was quenched and cells were analyzed by
flow cytometry to determine intracellular bacte-
ria. C: Representative histograms show intracel-
lular bacteria. D: Quantification of intracellular
bacteria in MH-S cells preincubated with anti-
SR-A or isotype control (n 4). *P 0.05 versus
PBS-treated mice; †P  0.05 versus isotype con-
trol, analysis of variance. MFI, mean fluores-
cence intensity.mation and fail to develop mucus hypersecretion or gob-
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the findings from rodent smoke-exposure models some-
times contradict those for the human disease. For exam-
ple, maturation of lung dendritic cells was suppressed in
cigarette smoke-exposed mice, resulting in diminished
antigen-specific T-cell proliferation in their regional lymph
nodes30; by contrast, lung dendritic cells in humans show
progressive increases in their expression of maturation
receptors from smokers with preserved lung function
through worsening spirometrically defined COPD sever-
ity.31 Whether the elastase/LPS model will mimic this and
other features of COPD in humans requires further inves-
tigation.
As an example of the utility of comparing data from
several sources, the deficiency we found in alveolar mac-
rophages from elastase/LPS-exposed mice to phagocy-
tose bacteria both in vivo and ex vivo is in accord with and
extends findings observed in alveolar macrophages iso-
lated from COPD patients11,12,14 and from mice exposed
to cigarette smoke.32 Because no portion of our in vivo
model involves cigarette smoke exposure, these data
imply that the alveolar macrophage phenotype can be
modified by the chronically inflamed lung environment
independently of any toxic effect of tobacco smoke.
Thus, this murine model system appears to be well suited
for investigation of the molecular mechanisms acting to
sustain the pathological changes in COPD that persist
after smoking cessation or that occur in never-smokers.
Other significant advantages of the elastase/LPS model
are the absence of a requirement for specialized expo-
sure equipment and the relatively short duration required
to produce robust structural and functional changes.
The findings that the expression by resident alveolar
macrophages of the class A scavengers was decreased
(MARCO) or absent (SR-A) in elastase/LPS-exposed
mice infected with NTHi is significant based on the mul-
tiple actions of these receptors in lung host de-
fense.16,17,33,34 Both SR-A and MARCO have been
shown to bind Gram-negative and Gram-positive bacte-
ria and to increase their uptake by macrophages.35–37
Collectively, our data extend those studies by demon-
strating a key role for SR-A in macrophage ingestion of
NTHi. Although we cannot rule out a contribution of
MARCO or of mannose receptor, a C-type lectin, in de-
creased bacterial phagocytosis by alveolar macro-
phages from elastase/LPS-exposed mice, we think that
the smaller magnitude of the difference in expression of
these receptors makes it less likely that they are essen-
tial. Our data are in accord with accumulating evidence for
reduced expression of MARCO in alveolar macrophages
from COPD patients and in macrophages exposed to cig-
arette smoke.14,38 Similarly, the slight increase in expres-
sion of SR-B (CD36) in alveolar macrophages of elastase/
LPS-exposed mice parallels findings in alveolar
macrophages isolated from COPD patients.14 Impor-
tantly, both SR-A and MARCO have also been shown to
interact with LPS, lipoteichoic acid, and other bacterial
cell-surface proteins.35,39,40 Not only do interactions of
SR-A with bacterial products or bacteria fail to activate
macrophages,35 but they actually dampen their proin-
flammatory response.41,42 Thus, together with the role wepreviously showed for this molecule in optimal efferocy-
tosis,22 the present results suggest the potential benefit
of therapies to increase alveolar macrophage expression
of class A scavenger receptors in COPD patients. How-
ever, we are unaware of any published report of SR-A
protein expression in alveolar macrophages in COPD, an
important future research direction.
The increased goblet cell metaplasia and expression
of Muc5AC in both large and peripheral airways in elas-
tase/LPS-exposed mice at 5 days after infection, relative
to infected PBS-exposed mice, is noteworthy, given the
clinical importance of the chronic bronchitic phenotype.
Chronic mucus hypersecretion in COPD patients has
been associated with impaired quality of life, accelerated
loss of lung function, greater health care utilization, and
increased mortality, relative to those without chronic spu-
tum production.43–45 These changes in our murine model
may be the direct effect of NTHi-induced TLR2 signaling
in bronchial epithelial cells,46 an indirect effect of cyto-
kines such as TNF- and IL-13 secreted by macro-
phages in response to infection, or both. Although the
TNF- response of elastase/LPS-exposed mice to NTHi
infection was lower at 1 day after infection, it persisted up
to 5 days after challenge (see Supplemental Figure S1 at
http://ajp.amjpathol.org). IL-13 was also marginally in-
creased in NTHi-infected elastase/LPS-exposed mice at
3 and 5 days after infection. NTHi is particularly associ-
ated with risk of exacerbation and chronic sputum pro-
duction,47 which provides opportunity for considerable
additional investigation in this and other model systems.
IL-13 and TNF- not only increase mucin secretion, but
also increase airway responsiveness to methacholine
challenge. Previously, we have shown that TNF- ex-
pressed in response to rhinovirus infection increases air-
way hyperresponsiveness and that blocking neutrophil-
elaborated TNF- partially inhibits rhinovirus-induced
airway hyperresponsiveness.48 TNF- also synergizes
with IL-13 to increase airway smooth muscle response to
cholinergic compounds.49 It is therefore conceivable that
increased IL-13 and TNF-may be in part responsible for
the observed increase in airway hyperresponsiveness to
methacholine challenge in NTHi-infected elastase/LPS-
exposed mice.
Acute exacerbations in COPD patients are often asso-
ciated with impairment of respiratory function for pro-
longed periods of time and sometimes with progression
of lung disease and increased mortality.50 These pro-
longed changes may be due to persistence of inflamma-
tory changes caused by the infecting organism. Consis-
tent with this notion, although elastase/LPS-exposed
mice cleared bacteria and partially resolved inflammation
by 15 days after NTHi infection, they showed further loss
of elastic recoil, indicating progression of emphysema.
This is a significant finding not previously shown in an
animal model of COPD.
In contrast to our present findings, and to previous
reports demonstrating impaired clearance of bacteria in
cigarette smoke-exposed mice after bacterial chal-
lenge,32,51 Gaschler et al52 found that mice exposed to
cigarette smoke for a short duration cleared NTHi more
rapidly after challenge, compared with room air-exposed
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NTHi-specific IgA.53 One explanation for the observed
discrepancy may be that mice exposed to cigarette
smoke for short durations do not up-regulate MMP-12, as
is seen in the elastase/LPS-exposed mice,24 in mice with
long-term exposure to cigarette smoke (6 months),54,55
and in sputum of COPD patients.56 Such increases in
MMP-12 in the airways can degrade IgA, which is in-
volved in NTHi clearance.53 Whether reduced airway IgA
resulting from the increased expression and activity of
MMP-12 that we previously observed in elastase/LPS-
exposed mice also contributes to the impaired bacterial
clearance reported here is beyond the scope of the pres-
ent study.
In conclusion, we have shown that during NTHi pulmo-
nary infection elastase/LPS-exposed mice, which de-
velop typical features of COPD within 4 weeks, clear the
organism more slowly and show sustained lung inflam-
mation and increased mucus production and progres-
sion of emphysema. Lack of SR-A expression in alveolar
macrophages may contribute to the observed defec-
tive clearance of bacteria in these mice. These findings
provide a murine model that complements smoke-ex-
posure models to investigate features common in the
COPD phenotype.
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